Futura are experts in transdermal delivery and have developed an advanced proprietary transdermal technology, DermaSys®.

Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain. Our lead product MED2005, is a breakthrough topical treatment for erectile dysfunction currently in Phase 3 clinical trial with potential peak sales of $1bn1.

 

1 Based on external market assessments from market research conducted by Cello Heath Consulting as a prescription product and Ipsos Group as an over the counter product